A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus
This study is ongoing, but not recruiting participants.
First Posted: October 16, 2012
Last Update Posted: August 17, 2017
Eli Lilly and Company
Information provided by (Responsible Party):